Multimodal AI prediction of head and neck cancer treatment outcomes with whole slide imaging.

J Jiaxiang Sun (The Ohio State University, Columbus, OH) Y Yusuf Sadek (The Ohio State University, Columbus, OH) Y Yiming Zhu (Shanghai Key Laboratory for R&D and Application of Metallic Functional Materials, Institute of New Energy for Vehicles, School of Materials Science and Engineering) S Sujith Baliga (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH) E Emile Gogineni (The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH) J John C. Grecula (The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH) D David Joseph Konieczkowski (The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH) D Darrion L. Mitchell (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH) M Marcelo Raul Bonomi (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH) P Priyanka Bhateja (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH) M Mateus Trinconi Cunha (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH) J James William Rocco (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH) A Arnab Chakravarti (James Cancer Hospital and Solove Research Institute, Columbus, OH) D Dukagjin Blakaj (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH) A Abberly Lott Limbach (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH) K Khalid Niazi (Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH) S Sung Jun Ma (The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH) S Simeng Zhu

Abstract

e18000 Background: Current risk stratification and adjuvant treatment decisions for head and neck cancer following surgical resection rely primarily on pathological risk factors. The growing adoption of digital pathology presents an opportunity to leverage histopathological image features to enhance risk stratification accuracy. This study investigated the performance of machine learning models for treatment outcome prediction using image features and traditional clinical variables, and identified optimal strategies for combining these modalities. Methods: We analyzed data from 645 patients in the publicly available HANCOCK dataset for model development and testing. All patients had head and neck cancers treated with primary surgery with or without adjuvant therapy. For each patient, H&E-stained whole slide images of the primary tumor and nine clinical variables served as model inputs. Slide-level image embeddings were extracted using a pretrained vision-language pathology foundation model (TITAN). Clinical variables included tumor site, pT classification, pN classification, histologic grade, perineural invasion, lymphovascular invasion, extranodal extension, margin status, and smoking history. Models were trained to predict survival, with performance measured by Harrell's concordance index (C-index), using an machine learning-based Cox proportional hazards model (DeepSurv). We compared unimodal models (using either clinical variables or image features alone) with multimodal models utilizing different fusion strategies (concatenation, late fusion, and cross-attention). Five-fold cross-validation with early stopping was implemented during training. Results: Unimodal models achieved C-indices of 0.62 +/- 0.04 (clinical variables) and 0.65 +/- 0.07 (image features). Multimodal models demonstrated progressive improvement: late fusion (0.63 +/- 0.05), concatenation (0.67 +/- 0.07), and cross-attention (0.69 +/- 0.07), with cross-attention achieving the highest performance. Conclusions: H&E-stained whole slide images from resected head and neck cancers contain significant prognostic information. Multimodal AI models integrating histopathological images with clinical variables, particularly using cross-attention fusion, enhance prognostic prediction and may improve risk stratification for adjuvant therapy decisions. Harrell's concordance index for each type of model input and feature fusion methods. Model input C-index (mean +/- std) Clinical variables alone 0.62 +/- 0.04 Image features alone 0.65 +/- 0.07 Multimodal (late fusion) 0.63 +/- 0.05 Multimodal (concatenation) 0.67 +/- 0.07 Multimodal (cross attention) 0.69 +/- 0.07

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (18)

J

Jiaxiang Sun

The Ohio State University, Columbus, OH

Y

Yusuf Sadek

The Ohio State University, Columbus, OH

Y

Yiming Zhu

Shanghai Key Laboratory for R&D and Application of Metallic Functional Materials, Institute of New Energy for Vehicles, School of Materials Science and Engineering

S

Sujith Baliga

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

E

Emile Gogineni

The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH

J

John C. Grecula

The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH

D

David Joseph Konieczkowski

The Ohio State University Comprehensive Cancer Center - The James Cancer Hospital and Solove Research Institute, Columbus, OH

D

Darrion L. Mitchell

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

M

Marcelo Raul Bonomi

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

P

Priyanka Bhateja

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

M

Mateus Trinconi Cunha

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

J

James William Rocco

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

A

Arnab Chakravarti

James Cancer Hospital and Solove Research Institute, Columbus, OH

D

Dukagjin Blakaj

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

A

Abberly Lott Limbach

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

K

Khalid Niazi

Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH

S

Sung Jun Ma

The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

S

Simeng Zhu